CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Clinical trials for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY trials appear
Sign up with your email to follow new studies for CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CIDP drug shows promise in Head-to-Head trial against standard care
Disease control Recruiting nowThis study compares a new intravenous drug, empasiprubart, to standard intravenous immunoglobulin (IVIg) in 218 adults with chronic inflammatory demyelinating polyneuropathy (CIDP), a nerve disorder causing weakness and numbness. Participants first receive either empasiprubart or…
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Smartwatches could spot nerve disease worsening before symptoms appear
Knowledge-focused Recruiting nowThis study looks at whether a smartwatch can help track how well treatment is working for people with CIDP, a rare nerve disease that causes weakness and numbness. About 35 adults who use daily immunoglobulin shots at home will wear a smartwatch for 12 months. Researchers will co…
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC
-
New study tracks drug safety for pregnant women with nerve disorders
Knowledge-focused Recruiting nowThis study follows pregnant or breastfeeding women who have taken efgartigimod for myasthenia gravis or CIDP. Researchers will monitor mothers, fetuses, and infants for any health issues, including birth defects. The goal is to gather safety data, not to test a new treatment.
Matched conditions: CIDP - CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Sponsor: argenx • Aim: Knowledge-focused
Last updated May 11, 2026 20:38 UTC